Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.
Arthur LetellierAlison C JohnsonNicolas How KitJean-François SavignyAlain BatallaJean-Jacques ParientiNicolas AidePublished in: Molecular imaging and biology (2019)
SUVmax and SUVmean on baseline [18F]NaF PET/CT are independent predictors of bone lesions' response to 3 cycles of radium-223 dichloride, supporting the use of NaF to select patients more likely to respond to treatment.